• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Alu介导的第11外显子重复和缺失是导致失活的常见机制,使个体易患遗传性乳腺癌-卵巢癌综合征。

Alu-Mediated Duplication and Deletion of Exon 11 Are Frequent Mechanisms of Inactivation, Predisposing Individuals to Hereditary Breast-Ovarian Cancer Syndrome.

作者信息

Sidoti Diletta, Margotta Valeria, Calosci Diletta, Fiorentini Erika, Bacci Costanza, Gensini Francesca, Papi Laura, Montini Marco

机构信息

Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, 50139 Florence, Italy.

Medical Genetics Unit, SOS Day-Service Palagi, USL Toscana Centro, 50122 Florence, Italy.

出版信息

Cancers (Basel). 2024 Nov 30;16(23):4022. doi: 10.3390/cancers16234022.

DOI:10.3390/cancers16234022
PMID:39682206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11640139/
Abstract

BACKGROUND/OBJECTIVE: Large genomic rearrangements of gene, particularly deletions and duplications, have been linked to hereditary breast-ovarian cancer. Our research specifically focuses on delineating the intronic breakpoints associated with rearrangements of exon 11, which is crucial for understanding the mechanisms underlying these genomic changes in patients with hereditary breast and ovarian syndrome.

METHODS

By using next-generation sequencing, we identified one duplication and three deletions of exon 11, confirmed by Multiplex Ligation-Dependent Probe Amplification analysis. To assess the impact on transcription and potential splicing issues, reverse-transcription PCR was performed on patients' RNA. For the detailed characterization of intronic breakpoints, the primer walking approach and long-range PCR were implemented, followed by Sanger sequencing.

RESULTS

Our analysis revealed a tandem duplication of 5134 base pairs (bp) mediated by repeats located in introns 10 and 11, respectively. Moreover, identical deletions were identified in three unrelated patients, encompassing an approximate 8050 bp region mediated by elements. Both genomic alterations resulted in a truncated protein due to the introduction of a premature stop codon.

CONCLUSIONS

This study underscores the remarkable instability of intronic regions flanking exon 11 of and identifies a previously unreported hotspot involving repeats with very high sequence homology in introns 10 and 11 of the gene. Our findings suggest avenues for further research, such as investigating the prevalence of similar genomic rearrangements in larger cohorts and exploring functional studies to understand how these alterations contribute to hereditary breast cancer pathogenesis.

摘要

背景/目的:基因的大型基因组重排,尤其是缺失和重复,与遗传性乳腺癌-卵巢癌相关。我们的研究特别专注于描绘与外显子11重排相关的内含子断点,这对于理解遗传性乳腺癌和卵巢综合征患者这些基因组变化的潜在机制至关重要。

方法

通过使用下一代测序技术,我们鉴定出了外显子11的一处重复和三处缺失,并通过多重连接依赖探针扩增分析得到证实。为了评估对转录的影响以及潜在的剪接问题,对患者的RNA进行了逆转录PCR。为了详细表征内含子断点,采用了引物步移法和长距离PCR,随后进行桑格测序。

结果

我们的分析揭示了一个由分别位于内含子10和11中的重复序列介导的5134个碱基对(bp)的串联重复。此外,在三名无亲缘关系的患者中鉴定出了相同的缺失,缺失区域约为8050 bp,由元件介导。这两种基因组改变均由于引入了提前终止密码子而导致蛋白质截短。

结论

本研究强调了基因外显子11侧翼内含子区域的显著不稳定性,并鉴定出了一个先前未报道的热点,该热点涉及基因内含子10和11中具有非常高序列同源性的重复序列。我们的发现为进一步研究指明了方向,例如调查更大队列中类似基因组重排的发生率,以及开展功能研究以了解这些改变如何导致遗传性乳腺癌的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/339ef8c66422/cancers-16-04022-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/aa3f549b8370/cancers-16-04022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/e12b3a19d7f5/cancers-16-04022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/8a69e306a882/cancers-16-04022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/817d7b47e68f/cancers-16-04022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/d503c46a2010/cancers-16-04022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/3348d06c56ec/cancers-16-04022-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/339ef8c66422/cancers-16-04022-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/aa3f549b8370/cancers-16-04022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/e12b3a19d7f5/cancers-16-04022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/8a69e306a882/cancers-16-04022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/817d7b47e68f/cancers-16-04022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/d503c46a2010/cancers-16-04022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/3348d06c56ec/cancers-16-04022-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df49/11640139/339ef8c66422/cancers-16-04022-g007.jpg

相似文献

1
Alu-Mediated Duplication and Deletion of Exon 11 Are Frequent Mechanisms of Inactivation, Predisposing Individuals to Hereditary Breast-Ovarian Cancer Syndrome.Alu介导的第11外显子重复和缺失是导致失活的常见机制,使个体易患遗传性乳腺癌-卵巢癌综合征。
Cancers (Basel). 2024 Nov 30;16(23):4022. doi: 10.3390/cancers16234022.
2
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.一个遗传性乳腺癌和卵巢癌家族中新型种系 PALB2 重复的特征分析。
Breast Cancer Res Treat. 2016 Dec;160(3):447-456. doi: 10.1007/s10549-016-4021-7. Epub 2016 Oct 18.
3
Identification and Characterization of an Exonic Duplication in in a Man with Synchronous Breast and Prostate Cancer.在一名同时患有乳腺癌和前列腺癌的男性中鉴定和表征中的外显子重复。
Int J Mol Sci. 2022 Jan 8;23(2):667. doi: 10.3390/ijms23020667.
4
High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic.捷克共和国遗传性乳腺癌和卵巢癌综合征中BRCA1基因内重排的高发生率。
BMC Med Genet. 2007 Jun 11;8:32. doi: 10.1186/1471-2350-8-32.
5
The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.PALB2 基因是 BRCA1 和 BRCA2 阴性遗传性乳腺癌临床检测的一个强有力的候选基因。
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2323-32. doi: 10.1158/1055-9965.EPI-13-0745-T. Epub 2013 Oct 17.
6
Alpha-galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu-rich gene.导致法布里病的α-半乳糖苷酶A基因重排。富含Alu序列基因断点处短直接重复序列的鉴定。
J Biol Chem. 1990 Jun 5;265(16):9319-26.
7
Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.芬兰乳腺癌和卵巢癌家族中BRCA1、BRCA2和PALB2基因大片段缺失的分析。
BMC Cancer. 2008 May 26;8:146. doi: 10.1186/1471-2407-8-146.
8
Pathogenicity reclassification of two BRCA1/BRCA2 exonic duplications after identification of genomic breakpoints and tandem orientation.在确定基因组断点和串联方向后对两个BRCA1/BRCA2外显子重复进行致病性重新分类。
Cancer Genet. 2020 Oct;248-249:18-24. doi: 10.1016/j.cancergen.2020.09.001. Epub 2020 Sep 11.
9
Alu-specific microhomology-mediated deletion of the final exon of SPAST in three unrelated subjects with hereditary spastic paraplegia.三个遗传性痉挛性截瘫患者中外显子最后区域的 Alu 特异微同源介导缺失。
Genet Med. 2011 Jun;13(6):582-92. doi: 10.1097/GIM.0b013e3182106775.
10
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.BRCA1大片段基因组重排在巴基斯坦早发性和家族性乳腺癌/卵巢癌中的作用。
Breast Cancer Res Treat. 2017 Jan;161(2):191-201. doi: 10.1007/s10549-016-4044-0. Epub 2016 Nov 8.

引用本文的文献

1
Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different Approaches.乳腺癌的生殖系检测:一项比较不同方法优缺点的单中心分析
Cancers (Basel). 2025 Apr 24;17(9):1419. doi: 10.3390/cancers17091419.

本文引用的文献

1
Characterizing intragenic duplication breakpoints in a triple-negative breast cancer case using long-read sequencing.使用长读长测序对一例三阴性乳腺癌病例中的基因内重复断点进行特征分析。
Front Oncol. 2024 Feb 28;14:1355715. doi: 10.3389/fonc.2024.1355715. eCollection 2024.
2
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing.遗传性乳腺癌和卵巢癌的基因基础:三十年来遗传性易感性检测的方法和经验教训。
Genes (Basel). 2024 Feb 8;15(2):219. doi: 10.3390/genes15020219.
3
Gender-Specific Genetic Predisposition to Breast Cancer: Genes and Beyond.
乳腺癌的性别特异性遗传易感性:基因及其他因素
Cancers (Basel). 2024 Jan 30;16(3):579. doi: 10.3390/cancers16030579.
4
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.美国国立综合癌症网络(NCCN)指南见解:遗传/家族性高风险评估:乳腺癌、卵巢癌和胰腺癌,2024年第2版
J Natl Compr Canc Netw. 2023 Oct;21(10):1000-1010. doi: 10.6004/jnccn.2023.0051.
5
Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer.变异扩展了匈牙利乳腺癌和卵巢癌患者的突变谱。
Cancers (Basel). 2023 Aug 31;15(17):4350. doi: 10.3390/cancers15174350.
6
Management of PALB2-associated breast cancer: A literature review and case report.PALB2相关乳腺癌的管理:文献综述与病例报告
Clin Case Rep. 2023 Aug 22;11(8):e7747. doi: 10.1002/ccr3.7747. eCollection 2023 Aug.
7
Gene of the month: PALB2.本月基因:PALB2。
J Clin Pathol. 2023 Feb;76(2):73-75. doi: 10.1136/jcp-2022-208461. Epub 2022 Dec 7.
8
Contribution of large genomic rearrangements in to familial breast cancer: implications for genetic testing.大片段基因组重排在家族性乳腺癌中的作用:对遗传检测的影响。
J Med Genet. 2023 Feb;60(2):112-118. doi: 10.1136/jmedgenet-2021-108399. Epub 2022 Apr 8.
9
Identification and Characterization of an Exonic Duplication in in a Man with Synchronous Breast and Prostate Cancer.在一名同时患有乳腺癌和前列腺癌的男性中鉴定和表征中的外显子重复。
Int J Mol Sci. 2022 Jan 8;23(2):667. doi: 10.3390/ijms23020667.
10
DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects.DNA 拷贝数变异:主要特征、进化意义和病理方面。
Biomed J. 2021 Oct;44(5):548-559. doi: 10.1016/j.bj.2021.02.003. Epub 2021 Feb 13.